Because β-adrenergic antagonists are beneficial in established CHF, we tested whether reduced β-adrenergic regulation caused by mutation of phoshoregulatory sites on CaV1.2 channels would be beneficial in pressure overload-induced CHF or would exacerbate this pathological condition. This evidence concerns the gene CACNA1C and congestive heart failure.